Molecular diagnosis is a dynamic area in constant development that has revolutionized clinical diagnosis. The specific detection and quantification of genetic material in a biological sample has shown a significant impact in all areas of health, especially in the areas of infectious diseases and cancer. The development of new, faster and more accurate technologies has transformed molecular diagnosis into a key tool for the clinical team for the direct benefit of the patient. The high sensitivity and specificity of the PCR technique allows for the early diagnosis of infectious agents or tumors and monitoring of disease progression and response to treatment.

With the emergence of SARS-CoV-2, molecular biology has taken on great relevance, being the technology of choice for its diagnosis and having a global reach. Hand in hand with all this growth and development, various technologies and formats have emerged that use molecular detection for the diagnosis of this and other viruses, creating a highly competitive market with multiple options. At Microbac we have been able to understand the changes in this market, adapting by selecting those options that satisfy the needs of our clients and provide a reliable solution to our patients.

It is in this context that our molecular biology diagnostic solutions are varied and target the different needs of the clinical laboratory.